Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study. (August 2022)

• Record Type: Journal Article
• Authors: Nayak, Debadatta; Gupta, Juhi; Chaudhary, Anupriya; Singh, Krishna Gopal; Deshmukh, Abhijeet; Das, Deblina; Saha, Abhishek; Kumar, Deepak; Kumar, Ashwini; Goenka, Ajay; Mishra, S.K.; Gupta, Sanjay; Khurana, Anil
• Is Part Of: Complementary therapies in clinical practice. Volume 48(2022)
• Publication Date: 2022-08
• Subjects: Integrative medicine -- Periodicals; Integrative medicine -- Research -- Periodicals; Alternative medicine -- Periodicals; 615.5
• DOI: 10.1016/j.ctcp.2022.101602
• Languages: English
• ISSNs: 1744-3881

Abstract

Highlights: A randomized, placebo-controlled trial of adjunct homeopathy with standard of care for COVID-19 was conducted on 300 patients. Primary outcome on total symptom score measured over 10 days decreased significantly favoring Standard of care + Homeopathy. Recovery was earlier in Standard of care + Homeopathy group by 02 days showing the added benefits of homeopathy. Resolution of fever was 20 h earlier in Standard of care + Homeopathy. Arsenicum album, Bryonia alba and Phosphorus were the most frequently prescribed medicines.